PHS
MRUS

PFM Health Sciences’s Merus MRUS Stock Holding History

PFM Health Sciences’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-130,742
Closed -$12.3M – 96
2025
Q3 		$12.3M Sell
130,742
-53,140
-29% -$3.46M 0.95% 35
2025
Q2 		$9.67M Buy
+183,882
New +$8.64M 0.82% 36

Other funds holding MRUS

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PFM Health Sciences's MRUS Position: Q4 2025 in Review

PFM Health Sciences sold out of Merus (MRUS) in Q4 2025, closing a stake of 130,742 shares — an estimated $12.3M sold.

PFM Health Sciences first reported a position in MRUS in Q2 2025 and held it in 2 quarters. The position peaked at $12.3M in Q3 2025. 10 funds tracked by Wall St. Rank hold MRUS as of Q4 2025.

  • PFM Health Sciences reported no remaining Merus position as of Q4 2025 after selling out during the quarter.
  • PFM Health Sciences sold 130,742 Merus shares in Q4 2025, an estimated $12.3M.
  • PFM Health Sciences first reported a position in Merus in Q2 2025 and held it in 2 quarters.
  • PFM Health Sciences's Merus position peaked at $12.3M in Q3 2025.
  • 10 funds tracked by Wall St. Rank held Merus as of Q4 2025.

Based on PFM Health Sciences's 13F filing for Q4 2025, filed 17 Feb 2026.